Enterprise services made accessible to

aspiring enterprises



Business Transformation & Information Security Consulting Services


Architecture

  • Business Architecture
  • Enterprise Architecture
  • Solutions Architecture
  • IT Strategy
  • Roadmaps







View Details


Business Transformation

  •  IT optimisation
  • Workshops for improving or creating a Digital Culture
  • IS, IT and other policy writing





View Details


Information Security

  • One-off Information Security Audit
  • Virtual Security Consultant
  • Security Architecture
  • ISO27001 implementation
  • Other Information Security Standard implementation
  • Build a cybersecurity capability



View Details


Team Development

  • Professional mentoring for people wanting to get into cybersecurity
  • Executive & Senior Leadership Coaching (coming 2024)




View Details


Business Development

  • Pre-sales representation and bid work
  • Syllogistic templates with copyright






View Details


Free Consultation

  • Book a complimentary call to discuss your needs today







Book Now

Discuss your needs with a free discovery call

BOOK NOW

The Latest from our Information Security blog


by Kurt Haynes 03 Oct, 2023
There are several factors that may be holding the pharma industry back from better information security practices: Resource constraints: Many pharma companies may not have the resources or expertise to implement the latest security technologies and practices. This can leave them vulnerable to attacks and data breaches. Lack of awareness: Some pharma companies may not be fully aware of the extent of the cybersecurity threat landscape and the potential risks to their business. This can lead to complacency and a lack of investment in cybersecurity measures. Legacy systems: Many pharma companies rely on legacy systems that may not be compatible with newer security technologies. This can make it difficult to implement effective security controls and upgrade their cybersecurity infrastructure. Complexity: The pharma industry is highly complex, with numerous stakeholders and a vast amount of sensitive data that must be protected. This complexity can make it difficult to implement effective security controls and ensure that all stakeholders are following best practices. Regulatory compliance: While regulatory compliance is important for protecting patient data and ensuring the safety and efficacy of drugs, it can also be a barrier to implementing new security technologies and practices. Compliance requirements can be complex and time-consuming to meet, which can divert resources from other security initiatives. Perception: Many decision makers in the industry who are not knowledgeable enough about information security and the risk based approach, assume that more security means more steps to complete a task and a bad user experience. They do not realise that in most cases the best practice either replaces insecure steps rather than adding more or the user experience can be made more secure and easier for the user by embracing newer technology. Overall, the pharma industry must overcome these challenges to implement better information security practices and protect their critical assets from cyber threats. This will require a concerted effort from all stakeholders, including industry leaders, regulators, and cybersecurity experts. Kurt Haynes MSc CISSP CCSP CISM CDPSE
quotesArtboard 1 copy 2

I had the pleasure of working with Syllogistic Consulting at PRMA, where Kurt conducted an IT & data security audit, implemented IT and organisational changes to address shortfalls and led the work to achieve ISO27001 certification for the company. Kurt was extremely knowledgeable and capable and was the driving force behind our success in securing ISO27001 certification. Above all, his collaborative, inclusive and engaging leadership style stood out, allowing him to get the whole PRMA organisation behind him in the work and invested fully in its success.

Giles Monnickendam

Director, PRMA Consulting

Share by: